Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldblatt

Showing results (601-610 of 1,168) with videos related to

Pageof 117
Sort By:
Clinical & Translational Immunology|January 10, 2022
Maintained partial protection against <i>Streptococcus pneumoniae</i> despite B-cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccineGiuseppe Ercoli, Elisa Ramos-Sevillano, Emma Pearce, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2000
Association between plasma CC16 levels, the A38G polymorphism, and asthmaI A Laing, C Hermans, A Bernard, et al.
International Journal of Cancer|May 1, 2013
Identification of hepatic microvascular adhesion-related genes of human colon cancer cells using random homozygous gene perturbationJoana Márquez, Manu Kohli, Beatriz Arteta, et al.
Cancer Research|May 1, 1977
Isolation and partial characterization of plasma membranes bearing human fetal-associated antigensR Akeson, D Goldblatt, A Adey, et al.
The Pediatric Infectious Disease Journal|December 17, 2009
Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United KingdomDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
The Pediatric Infectious Disease Journal|April 19, 2016
The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early InfancyJohannes Trück, Sena Jawad, David Goldblatt, et al.
Vaccine|November 1, 2015
Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patchFrances E Pearson, David A Muller, Lucy Roalfe, et al.
American Journal of Medical Genetics|July 1, 1985
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patientsG A Grabowski, J Goldblatt, T Dinur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 yearsDavid Goldblatt, Jo Southern, Nick Andrews, et al.
JIMD Reports|February 23, 2013
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experienceJoanna Ghali, Kathy Nicholls, Charles Denaro, et al.
Pageof 117

Showing results (601-610 of 1,168) with videos related to

Sort By:
Pageof 117
Clinical & Translational Immunology|January 10, 2022
Maintained partial protection against <i>Streptococcus pneumoniae</i> despite B-cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccineGiuseppe Ercoli, Elisa Ramos-Sevillano, Emma Pearce, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2000
Association between plasma CC16 levels, the A38G polymorphism, and asthmaI A Laing, C Hermans, A Bernard, et al.
International Journal of Cancer|May 1, 2013
Identification of hepatic microvascular adhesion-related genes of human colon cancer cells using random homozygous gene perturbationJoana Márquez, Manu Kohli, Beatriz Arteta, et al.
Cancer Research|May 1, 1977
Isolation and partial characterization of plasma membranes bearing human fetal-associated antigensR Akeson, D Goldblatt, A Adey, et al.
The Pediatric Infectious Disease Journal|December 17, 2009
Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United KingdomDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
The Pediatric Infectious Disease Journal|April 19, 2016
The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early InfancyJohannes Trück, Sena Jawad, David Goldblatt, et al.
Vaccine|November 1, 2015
Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patchFrances E Pearson, David A Muller, Lucy Roalfe, et al.
American Journal of Medical Genetics|July 1, 1985
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patientsG A Grabowski, J Goldblatt, T Dinur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 yearsDavid Goldblatt, Jo Southern, Nick Andrews, et al.
JIMD Reports|February 23, 2013
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experienceJoanna Ghali, Kathy Nicholls, Charles Denaro, et al.
Pageof 117